NOROTYL LA (TYLOSIN INJECTABLE SUSPENSION) DIN 02295725
Health Canada record
| Active ingredient(s) | TYLOSIN 150 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 10-Sep-2007 |
| Current status date | 31-Jul-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Norbrook Laboratories Limited — licence , not currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TYLOSIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00103594 | TYLAN 200 | ELANCO CANADA LIMITED | Solution | TYLOSIN 200 MG | Dormant |
| 00103586 | TYLAN 50 FOR INJ 50MG | ELANCO DIVISION ELI LILLY CANADA INC | Liquid | TYLOSIN 50 MG | Cancelled Post Market |
| 00079219 | TYLOCINE INJ 200MG/ML | CORVEL, DIVISION OF ELI LILLY CANADA INC. | Liquid | TYLOSIN 200 MG | Cancelled Post Market |
| 00079200 | TYLOCINE INJ 50MG/ML | CORVEL, DIVISION OF ELI LILLY CANADA INC. | Liquid | TYLOSIN 50 MG | Cancelled Post Market |
| 00079227 | TYLOCINE TAB 200MG | CORVEL, DIVISION OF ELI LILLY CANADA INC. | Tablet | TYLOSIN 200 MG | Cancelled Post Market |
| 01923803 | TYLOCINE TAB 200MG | ELI LILLY CANADA INC | Tablet | TYLOSIN 200 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 9702 | 2008-08-01 | Supplement to a New Drug Submission (SNDS) | CHANGE IN WITHDRAWAL PERIOD |
| 8804 | 2007-05-30 | New Drug Submission (NDS) |
International API supply for TYLOSIN
0 active FDA Drug Master Files.
Request a quote for NOROTYL LA (TYLOSIN INJECTABLE SUSPENSION)